AAAlexandre Alessi

Alexandre Alessi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandre Alessi has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rara Apresentação de Anomalia Congênita Anatômica de Artérias Coronárias em Exame de Angiotomografia

    by Marcello Zapparoli, Alexandre Alessi, Franco Camargo Zapparoli, Mateus Rodrigues Alessi

    Introdução A origem anômala das artérias coronárias representa um grupo heterogêneo de alterações na origem e trajeto destes vasos, variando desde as mais

  • Open Access

    Rare Presentation of an Anatomical Congenital Anomaly of the Coronary Arteries on Computed Tomography Angiography

    by Marcello Zapparoli, Alexandre Alessi, Franco Camargo Zapparoli, Mateus Rodrigues Alessi

    Introduction Anomalous origin of the coronary arteries represents a heterogeneous group of alterations in the origin and course of these vessels, ranging

  • Open Access

    Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023

    by Audes Diogenes de Magalhães Feitosa, Weimar Kunz Sebba Barroso, Decio Mion Junior, Fernando Nobre, Marco Antonio Mota-Gomes, Paulo Cesar Brandão Veiga Jardim, Celso Amodeo, Adriana Camargo Oliveira, Alexandre Alessi, Ana Luiza Lima Sousa, et al.

    Table of contents Updates and modifications to the Brazilian Guidelines for In-Office and Out-of-Office Blood Pressure Measurement 10 Part 1 – Blood pressure measurement 10 […] Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023 Table of contents Updates and modifications to the Brazilian Guidelines for In-Office and Out-of-Office Blood Pressure Measurement 10 Part 1 – Blood pressure measurement 10 […] Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023


  • Open Access

    Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023

    by Audes Diogenes de Magalhães Feitosa, Weimar Kunz Sebba Barroso, Decio Mion Junior, Fernando Nobre, Marco Antonio Mota-Gomes, Paulo Cesar Brandão Veiga Jardim, Celso Amodeo, Adriana Camargo Oliveira, Alexandre Alessi, Ana Luiza Lima Sousa, et al.

    Sumário Atualizações e Mudanças nas Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório 10 Parte 1 – Medidas da Pressão Arterial 10 […] Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023 Sumário Atualizações e Mudanças nas Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório 10 Parte 1 – Medidas da Pressão Arterial 10 […] Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023


  • Top Cited Papers
    Open Access

    Diretrizes Brasileiras de Hipertensão Arterial – 2020

    by Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, Marco Antônio Mota-Gomes, Andréa Araujo Brandão, Audes Diógenes de Magalhães Feitosa, Carlos Alberto Machado, Carlos Eduardo Poli-De-Figueiredo, Celso Amodeo, Décio Mion, et al.

    Sumário 1. Definição, Epidemiologia e Prevenção Primária 528 1.1 Definição de Hipertensão Arterial 528 […] Diretrizes Brasileiras de Hipertensão Arterial – 2020 Sumário 1. Definição, Epidemiologia e Prevenção Primária 528 1.1 Definição de Hipertensão Arterial 528 […] Diretrizes Brasileiras de Hipertensão Arterial – 2020


  • Open Access

    Appropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice

    by Liz Andréa Villela Baroncini, Aguinaldo de Oliveira, Enrique Antonio Vidal, Graciliano José França, Paulo Sérgio Dalla Bona Stahlke, Alexandre Alessi, Dalton Bertolim Précoma

    To describe the findings and evaluate appropriateness of a carotid artery study including the measurement of IMT, the presence of atherosclerotic plaque, and their correlation with cardiovascular risk factors. 555 patients (220 men; 67.06 +/- 12.44 years) were included in the study. 120 patients (21.62%) presented carotid plaque: 108 (19.45%) in patients with at least one risk factor and 12 (2.1%) in patients without risk factors. With respect to appropriateness of the present studies: 65% were appropriate, 22% were uncertain and 13% were inappropriate. The IMT medians were higher in males (0.0280; 95% CI, 00.82 to 0.478; p = 0.0057) and in hypertensive patients (0.391; 95% CI, 0.0190 to 0.0592; p = 0,001). There was a linear increase in mean IMT for each year increased in age (0.0059; 95% CI; 0.0050 to 0.0067). Carotid plaque was more frequent in patients with CAD (p = 0.0002), diabetes (p = 0.024) and hypertension (p = 0.036). Assessment of carotid arteries identified increased incidence of plaque in patients with CAD, diabetes and hypertension. IMT was increased in older patients, hypertensive patients and males. Forty-five percent of the patients were studied based on uncertain and inappropriate reasons.


  • Open Access

    Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation

    by Alexandre Alessi, Olímpio Ribeiro França Neto, Paulo Roberto Slud Brofman, Camila Prim, Lucia Noronha, Ruy Fernando Kuenzer Caetano Silva, Liz Andréa Villela Baroncini, Dalton Bertolim Précoma

    Objectives: To analyse the effects of rosiglitazone administered at different times on neointimal formation in hypercholesterolemic rabbits following vascular injury. Methods: Thirty-nine rabbits on a hypercholesterolemic diet were included. The animals underwent balloon catheter injury to the right iliac artery on day 14. They were divided into three groups as follows: control group, 13 rabbits without rosiglitazone; group I, 13 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) for 28 days after the vascular injury; and group II, 13 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during all the experiment (42 days). Histological analysis was done by an experienced pathologist who was unaware of the rosiglitazone treatment. Histomorphometric parameters were performed by calculation of the luminal and intimal layer area, and intima/media layer area ratio (the area of the intimal layer divided by the area of the medial layer). Results: Intimal area was significantly lower in group II vs. CG (p = 0.024) and group I (p = 0.006). Luminal layer area was higher in group II vs. CG (p < 0.0001) and group I (p < 0.0001). Intima/media layer area ratio was equal between CG and group I. Intima/media layer ratio area was significantly lower in group II vs. control group (p < 0.021) and group I (p < 0.003). There was a significant reduction of 65% and 71% in intima/media layer area ratio in group II vs. control group and group I, respectively. Conclusion: Pretreatment with rosiglitazone in hypercholesterolemic rabbits submitted to vascular injury significantly reduces neointimal formation.


  • Open Access

    Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits

    by Olímpio Ribeiro França Neto, Dalton Bertolim Precoma, Alexandre Alessi, Camila Prim, Ruy FernandoKuenzerCaetano da Silva, Lucia de Noronha, Liz Andréavillela Baroncini

    Background: The objective was to evaluate the effects of rosiglitazone on iliac arteries of hypercholesterolemic rabbits undergoing balloon catheter injury in the contralateral iliac arteries. Methods: White male rabbits were fed a hypercholesterolemic diet for 6 weeks and divided into two groups as follows: rosiglitazone group, 14 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during 6 weeks; and control group, 18 rabbits without rosiglitazone treatment. All animals underwent balloon catheter injury of the right iliac artery on the fourteenth day of the experiment. Results: There was no significant difference in intima/media layer area ratio between the control group and the rosiglitazone group. Rosiglitazone did not reduce the probability of lesions types I, II, or III (72.73% vs. 92.31%; p = 0.30) and types IV or V (27.27% vs. 7.69%; p = 0.30). There were no differences in the extent of collagen type I and III deposition or in the percentage of animals with macrophages in the intima layer. The percentage of rabbits with smooth muscle cells in the intima layer was higher in rosiglitazone group (p = 0.011). Conclusion: These findings demonstrate that rosiglitazone given for 6 weeks did not prevent atherogenesis at a vessel distant from the injury site.


  • Open Access

    Influence of Quality of Sleep on the Nocturnal Decline in Blood Pressure During Ambulatory Blood Pressure Monitoring

    by Alexandre Alessi, Cristiane Rodrigues Alessi, Edson Rogério Piana, Márcia Assis, Luciano Rodrigo Oliveira, Cláudio L. Pereira da Cunha

    OBJECTIVE: To assess the influence of the quality of sleep on the nocturnal physiological drop in blood pressure during ambulatory blood pressure monitoring. METHODS: We consecutively assessed ambulatory blood pressure monitoring, the degree of tolerance for the examination, and the quality of sleep in 168 patients with hypertension or with the suspected "white-coat" effect. Blood pressure fall during sleep associated with a specific questionnaire and an analogical visual scale of tolerance for ambulatory blood pressure monitoring were used to assess usual sleep and sleep on the day of examination. Two specialists in sleep disturbances classified the patients into 2 groups: those with normal sleep and those with abnormal sleep. RESULTS: Fifty-nine (35 %) patients comprised the abnormal sleep group. Findings regarding the quality of sleep on the day of ambulatory blood pressure monitoring as compared with those regarding the quality of sleep on a usual day were different and were as follows, respectively: total duration of sleep (-12.4±4.7 versus -42.2±14.9 minutes, P=0.02), latency of sleep (0.4±2.7 versus 17±5.1 minutes, P<0.001), number of awakenings (0.1±0.1 versus 1.35±0.3 times, P<0.001), and tolerance for ambulatory blood pressure monitoring (8±0.2 versus 6.7±0.35, P=0.035). An abnormal drop in blood pressure during sleep occurred in 20 (18%) patients in the normal sleep group and in 14 (24%) patients in the abnormal sleep group, P=0.53. CONCLUSION: Ambulatory blood pressure monitoring causes sleep disturbances in some patients, and a positive association between quality of sleep and tolerance for the examination was observed.